The outcome and the risk factors of mucormycosis among patients with hematological diseases: a systematic and meta-analysis.

ABSTRACT:

Objectives

Mucorale has come into a significant pathogen over recent decades. Nonetheless, mucormycosis-related mortality rates among patients with hematological disorders remain unascertained. Thus, we conducted a meta-analysis to determine mortality rates of mucormycosis in patients with hematology-related conditions.

Methods

We scoured PubMed, Embase, and Web of Science for original papers exploring the intersection of Mucormycosis and Hematological Diseases (from 2000 to 2022). We scrutinized the overall mortality across three distinct periods, as well as differentiating between high-income and middle-income nations. We further evaluated the pooled mortality and the risk differential (RD) across several subgroups.

Results

The overall mortality rate for hema

SUBMITTER: Shen M 

PROVIDER: S-EPMC10720036 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature